申请人:Takeda Chemical Industries, Ltd.
公开号:US04576760A1
公开(公告)日:1986-03-18
A compound of the formula: ##STR1## [wherein either one of R.sub.1 and R.sub.2 stands for hydrogen or SO.sub.3 H and the other is SO.sub.3 H, Z stands for ##STR2## (where m denotes an integer of 1-22, n denotes an integer of 0-21, R.sub.3 stands for hydrogen or an acyl group having 2 to 4 carbon atoms, and R.sub.4 is hydrogen or an alkyl group having 1 to 4 carbon atoms)] and pharmacologically acceptable salts thereof, which has various pharmacological actions such as antioxidative action, inhibitory action of SRS-A generation, immunoregulatory action, action on lysosome-membrane, cell-activating action, phosphodiesterase-inhibitory action, etc.
化合物的公式为:##STR1## [其中R.sub.1和R.sub.2中的任意一个为氢或SO.sub.3 H,另一个为SO.sub.3 H,Z代表##STR2##(其中m表示1-22的整数,n表示0-21的整数,R.sub.3代表氢或具有2至4个碳原子的酰基,R.sub.4为氢或具有1至4个碳原子的烷基),以及其药理学可接受的盐。该化合物具有多种药理作用,如抗氧化作用、抑制SRS-A生成作用、免疫调节作用、溶酶体膜作用、细胞激活作用、磷酸二酯酶抑制作用等。